Autolus Therapeutics (AUTL)
NASDAQ: AUTL
· Real-Time Price · USD
2.31
-0.01 (-0.43%)
At close: Jun 26, 2025, 3:59 PM
2.29
-0.65%
After-hours: Jun 26, 2025, 07:52 PM EDT
-0.43% (1D)
| Bid | 2.25 |
| Market Cap | 613.45M |
| Revenue (ttm) | 9.01M |
| Net Income (ttm) | -238.13M |
| EPS (ttm) | -0.88 |
| PE Ratio (ttm) | -2.62 |
| Forward PE | -3.22 |
| Analyst | Buy |
| Ask | 2.36 |
| Volume | 1,076,314 |
| Avg. Volume (20D) | 2,316,811 |
| Open | 2.30 |
| Previous Close | 2.32 |
| Day's Range | 2.25 - 2.34 |
| 52-Week Range | 1.10 - 5.00 |
| Beta | 1.74 |
About AUTL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AUTL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AUTL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Autolus Therapeutics is scheduled to release its earnings on Aug 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+9.76%
Autolus Therapeutics shares are trading higher fol...
Unlock content with
Pro Subscription
2 months ago
-9.03%
Autolus Therapeutics shares are trading lower after Truist Securities cut its price target on the stock from $11 to $10.
